Prior to hospital admission, the patient's bronchial fluid produc¬ tion had been ranging between 2 and 3.5 L/d. Figure 1 shows the daily trend of bronchial fluid production and urine output for each hospital day. During the first hospital day, 3,200 mL was expecto¬ rated. Treatment with a somatostatin analogue, octreotide, 100 pg subcutaneously three times a day, was started on the second hos¬ pital day. Bronchial fluid production decreased to 2,480 mL on the second hospital day, and 2,500 mL on hospital day 3. The volume of bronchial fluid production increased slightly to 2,800 mL during hospital day 4. Therefore, the octreotide dose was increased to 250

